
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an uncommon blood cancer affecting various body parts. Pediatric BPDCN appears less aggressive clinically but often presents with a wider spread. Unlike adults, many children can be successfully treated with a high-risk acute lymphoblastic leukemia-like regimen without immediate stem cell transplantation. However, transplantation is still recommended for high-risk cases or relapsed/refractory situations. Exciting advancements include novel agents, and CD123 targeted therapies, potentially revolutionizing treatment approaches. A comprehensive review shed light on BPDCN's presentation, diagnosis, and treatment.
Like
Save
Share